SwanBio Therapeutics
Bala Cynwyd
About SwanBio Therapeutics
SwanBio Therapeutics is a developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological diseases. The company's technology focuses on the development and commercialisation of genetically defined therapies for the treatment of neurological disorders.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $118.0M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2023)
- Website: swanbiotx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/swanbio-therapeutics-6947 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.